Who
Nicholas Naclerio
Director
Company insider
Files Form 4 as: Director, Alamar Biosciences; Sr VP, Corporate Development, Illumina.
In numbers
- Trades disclosed
- 222
- Buys
- 1
- Sells
- 34
- Bought
- $8.0M
- Sold
- $39.7M
- Companies
- 2
- Companies where not an officer
- 1
- First trade
- 31 Jan 2012
- Last trade
- 20 Apr 2026
- Last filed
- 20 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar BiosciencesLife-science tools | SEC FORM 4 Code C | —4,588,364 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code C | —3,194,377 at $0.00 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code C | —2,862,507 at $0.00 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code C | —2,094,266 at $0.00 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code C | —5,037,783 at $0.00 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code C | — | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code C | — | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar BiosciencesLife-science tools | SEC FORM 4 Code C | —922,152 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar BiosciencesLife-science tools | SEC FORM 4 Code J | —5,510,516 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code C | —3,194,377 at $0.00 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code C | —2,862,507 at $0.00 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code C | —2,094,266 at $0.00 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code C | —5,037,783 at $0.00 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code C | — | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar Biosciencesoption or derivative · Life-science tools | SEC FORM 4 Code C | — | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar BiosciencesLife-science tools | SEC FORM 4 Code J | —5,510,516 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar BiosciencesLife-science tools | SEC FORM 4 Code C | —346,020 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar BiosciencesLife-science tools | SEC FORM 4 Code C | —271,782 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar BiosciencesLife-science tools | SEC FORM 4 Bought | $4.0M235,294 at $17.00 | filing |
| 20 Apr 2026filed 20 Apr 2026 | ALMR Alamar BiosciencesLife-science tools | SEC FORM 4 Code A | —5,686 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.